These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37105658)

  • 1. Syringe Services Programs to Reduce Intravenous Disease Transmission in Substance Use Disorders.
    Roberts HH; Stone M; Isac AJ
    Nurs Clin North Am; 2023 Jun; 58(2):243-256. PubMed ID: 37105658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringe services programs and real-world research: An overview for pharmacists.
    Carico RR; Hussain N; Sheppard J; Thomas CB; Fenerty J
    J Am Pharm Assoc (2003); 2020; 60(5):e29-e33. PubMed ID: 32278515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Police officer attitudes towards syringe services programming.
    Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
    Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
    McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
    Carnes NA; Asher AK; Bohm MK; Bessler PA
    Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injecting substance use in prisons in the United States: a case for needle exchange programs.
    Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
    Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overdose Education and Naloxone Distribution Within Syringe Service Programs - United States, 2019.
    Lambdin BH; Bluthenthal RN; Wenger LD; Wheeler E; Garner B; Lakosky P; Kral AH
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1117-1121. PubMed ID: 32817603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
    Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
    Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
    Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
    Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
    Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distributive Syringe Sharing and Use of Syringe Services Programs (SSPs) Among Persons Who Inject Drugs.
    Adams M; An Q; Broz D; Burnett J; Wejnert C; Paz-Bailey G;
    AIDS Behav; 2019 Dec; 23(12):3306-3314. PubMed ID: 31512066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017.
    Bixler D; Corby-Lee G; Proescholdbell S; Ramirez T; Kilkenny ME; LaRocco M; Childs R; Brumage MR; Settle AD; Teshale EH; Asher A
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(18):529-532. PubMed ID: 29746453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.
    Cloud DH; Castillo T; Brinkley-Rubinstein L; Dubey M; Childs R
    Curr HIV/AIDS Rep; 2018 Jun; 15(3):276-282. PubMed ID: 29740734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
    Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
    Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urgent need to expand syringe services programs in South Carolina and beyond.
    Pham Q; Burrows M; Litwin A
    Subst Abuse Treat Prev Policy; 2022 Jun; 17(1):47. PubMed ID: 35729624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
    Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
    Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.
    Fernández-Viña MH; Prood NE; Herpolsheimer A; Waimberg J; Burris S
    Public Health Rep; 2020; 135(1_suppl):128S-137S. PubMed ID: 32735195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.